<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Teskey G</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><pubmed_abstract>The storage and release of triacylglycerol (TAG) in lipid droplets (LDs) is regulated by dynamic protein interactions. α/β hydrolase domain-containing protein 5 (ABHD5; also known as CGI-58) is a membrane/LD bound protein that functions as a co-activator of Patatin Like Phospholipase Domain Containing 2 (PNPLA2; also known as Adipose triglyceride lipase, ATGL) the rate-limiting enzyme for TAG hydrolysis. The dysregulation of TAG hydrolysis is involved in various metabolic diseases such as metabolic dysfunction-associated steatotic liver disease (MASLD). We previously demonstrated that ABHD5 interacted with PNPLA3, a closely related family member to PNPLA2. Importantly, a common missense variant in PNPLA3 (I148M) is the greatest genetic risk factor for MASLD. PNPLA3 148M functions to seques</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.10.03.616525</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11601262</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Lipid droplet targeting of ABHD5 and PNPLA3 I148M is required to promote liver steatosis.</pubmed_title><pmcid>PMC11601262</pmcid><funding_grant_id>P30 DK092926</funding_grant_id><funding_grant_id>T32 HL120822</funding_grant_id><funding_grant_id>R01 DK126743</funding_grant_id><pubmed_authors>Butcko AJ</pubmed_authors><pubmed_authors>Huang YM</pubmed_authors><pubmed_authors>Kelly CV</pubmed_authors><pubmed_authors>Mottillo EP</pubmed_authors><pubmed_authors>Tiwari N</pubmed_authors><pubmed_authors>Granneman JG</pubmed_authors><pubmed_authors>Perfield JW</pubmed_authors><pubmed_authors>Teskey G</pubmed_authors><pubmed_authors>Kumar A</pubmed_authors><pubmed_authors>Yadav A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lipid droplet targeting of ABHD5 and PNPLA3 I148M is required to promote liver steatosis.</name><description>The storage and release of triacylglycerol (TAG) in lipid droplets (LDs) is regulated by dynamic protein interactions. α/β hydrolase domain-containing protein 5 (ABHD5; also known as CGI-58) is a membrane/LD bound protein that functions as a co-activator of Patatin Like Phospholipase Domain Containing 2 (PNPLA2; also known as Adipose triglyceride lipase, ATGL) the rate-limiting enzyme for TAG hydrolysis. The dysregulation of TAG hydrolysis is involved in various metabolic diseases such as metabolic dysfunction-associated steatotic liver disease (MASLD). We previously demonstrated that ABHD5 interacted with PNPLA3, a closely related family member to PNPLA2. Importantly, a common missense variant in PNPLA3 (I148M) is the greatest genetic risk factor for MASLD. PNPLA3 148M functions to seques</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-04-16T03:28:15.052Z</modification><creation>2025-04-06T01:56:07.792Z</creation></dates><accession>S-EPMC11601262</accession><cross_references><pubmed>39605541</pubmed><doi>10.1101/2024.10.03.616525</doi></cross_references></HashMap>